Trump Negotiating Deal With Ozempic Maker to Sell Some Weight-Loss Drugs for $149

The Trump administration is negotiating a deal with weight-loss drugmakers Eli Lilly LLY 1.15%increase; green up pointing triangle and Novo Nordisk NOVO.B -0.03%decrease; red down pointing triangle that would allow the lowest doses of some of their obesity drugs to be sold to consumers at $149 for a month’s supply via TrumpRx, according to people familiar with the matter.

The deals would also result in Medicare and Medicaid covering the drugs for weight loss, the people said, which would be a boon to the companies.